Ad
Thursday, 25 January 2018
U.S. panel rejects most of Philip Morris' iQOS tobacco device claims
WASHINGTON (Reuters) - Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment